Literature DB >> 11558275

[Study of the physiological and biochemical characteristics of bifidobacteria at the late stages of population development].

G I Novik1, N I Astapovich, A A Samartsev.   

Abstract

An investigation of the physiological and biochemical characteristics of the Bifidobacterium bifidum no. 1, B. adolescentis MC-42, and B. adolescentis 94-BIM strains showed that bifidobacteria with a higher growth rate produced greater amounts of the end fermentation products, acetate and lactate. The growth of the strains in batch cultures was found to be inhibited by acidic fermentation products. The growth of B. bifidum no. 1 in a batch mode lasted 100 h at a population density of 10(6) CFU/ml and the growth of B. adolescentis MC-42 and 94-BIM lasted 96-120 h at population densities from 10(4) to 10(7) CFU/ml. Analysis of the bifidobacterial populations by light and electron microscopy showed that they represent conglomerates of cells with lysed cytoplasm in the cell center and intact cytoplasm in the apical parts of the cells. The maximum production of extra-cellular and cell-bound proteinases was observed in the logarithmic growth phase. By the 120th h of cultivation, the metabolic activity of cells, the production of proteinases, and the protein content of bifidobacterial cultures considerably decreased. In the first, second, and third subcultures of 96-h-old bifidobacterial cells on fresh nutrient media, the population density of bifidobacteria and their normal physiological and biochemical characteristics were restored after 48 to 72 h of cultivation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11558275

Source DB:  PubMed          Journal:  Mikrobiologiia        ISSN: 0026-3656


  1 in total

1.  In Vitro Antibacterial Mechanism of Action of Crude Garlic (Allium sativum) Clove Extract on Selected Probiotic Bifidobacterium Species as Revealed by SEM, TEM, and SDS-PAGE Analysis.

Authors:  J Booyens; M C Labuschagne; M S Thantsha
Journal:  Probiotics Antimicrob Proteins       Date:  2014-06       Impact factor: 4.609

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.